Drug class
Bulk Laxatives
Bulk laxatives, also designated as bulk-forming laxatives, are a established therapeutic class of gastrointestinal agents composed of soluble or insoluble dietary fibers and hydrophilic polymers, such as psyllium, methylcellulose, and calcium polycarbophil. Read more about Bulk Laxatives
186 drugs in this class 39 manufacturers
Drugs in Bulk Laxatives
FIBER (calcium polycarbophil)
FIBER THERAPY (methylcellulose)
ONELAX FIBER THERAPY (psyllium husk (with sugar))
FIBER LAXATIVE (calcium polycarbophil)
FIBER-LAX (calcium polycarbophil)
FIBER LAXATIVE (methylcellulose)
FIBER TABS (calcium polycarbophil)
FIBER THERAPY (methylcellulose)
Bulk laxatives, also designated as bulk-forming laxatives, are a established therapeutic class of gastrointestinal agents composed of soluble or insoluble dietary fibers and hydrophilic polymers, such as psyllium, methylcellulose, and calcium polycarbophil.
They exert their principal therapeutic effect by absorbing fluid within the intestinal lumen, which increases fecal mass and softens stool consistency, thereby mechanically distending the colon wall to stimulate natural peristalsis and facilitate bowel evacuation.
Clinically, they serve as a first-line pharmacologic intervention for the prevention and management of simple or chronic constipation, irritable bowel syndrome with constipation (IBS-C), and conditions where straining must be minimized, such as diverticular disease, hemorrhoids, and anal fissures.
-
fda.gov
Bulk laxatives, also designated as bulk-forming laxatives, are a established therapeutic class of gastrointestinal agents composed of soluble or insoluble dietary fibers and hydrophilic polymers, such as psyllium, methylcellulose, and calcium polycarbophil
-
healthline.com
Bulk laxatives, also designated as bulk-forming laxatives, are a established therapeutic class of gastrointestinal agents composed of soluble or insoluble dietary fibers and hydrophilic polymers, such as psyllium, methylcellulose, and calcium polycarbophil They exert their principal therapeutic effect by absorbing fluid within the intestinal lumen, which increases fecal mass and softens stool consistency, thereby mechanically distending the colon wall to stimulate natural peristalsis and facilit...
-
nih.gov
They exert their principal therapeutic effect by absorbing fluid within the intestinal lumen, which increases fecal mass and softens stool consistency, thereby mechanically distending the colon wall to stimulate natural peristalsis and facilitate bowel evacuation
-
fda.gov
Clinically, they serve as a first-line pharmacologic intervention for the prevention and management of simple or chronic constipation, irritable bowel syndrome with constipation (IBS-C), and conditions where straining must be minimized, such as diverticular disease, hemorrhoids, and anal fissures
-
nih.gov
Clinically, they serve as a first-line pharmacologic intervention for the prevention and management of simple or chronic constipation, irritable bowel syndrome with constipation (IBS-C), and conditions where straining must be minimized, such as diverticular disease, hemorrhoids, and anal fissures
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.